Literature DB >> 6801131

Trypanosoma cruzi: induction of microbicidal activity in human mononuclear phagocytes.

N Nogueira, S Chaplan, M Reesink, J Tydings, Z A Cohn.   

Abstract

Antigen-stimulated peripheral blood mononuclear cells from 14 patients with chronic Chagas' disease were examined for their ability to generate soluble factor(s) capable of activating human macrophages to a microbicidal state. Mononuclear cell factors (MCF) from all but one patient were capable of inducing macrophages to a state where they were able to kill trypomastigotes of Trypanosoma cruzi. Macrophage microbicidal activity against this organism was nonspecific, because it could be induced by lymphokine from PPD-positive subjects exposed to heat-killed BCG or by concanavalin A stimulation of normal donors cells. A factor(s) generated by the stimulation of mononuclear cells from normal donors by T. cruzi antigen did not induce macrophage microbicidal activity. Opsonization of the organisms with specific IgG did not alter their fate in normal macrophages, but enhanced their killing in MCF-activated cells. Induction of macrophage activation in the human system differed from the results previously described in mice in a few features: 1) Optimal microbicidal activity did not require daily addition of the soluble factors. 2) The MCF dose-response curve was shifted to lower concentrations. 3) MCF activity generated by antigen-stimulated peripheral blood lymphocytes correlates with their proliferative responses to antigen. Half of the patients showed low proliferative responses and correspondingly lower MCF activity. Mitogen responses were normal in all patients. No correlation was found between low or high responses and clinical manifestations of disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Differences in microbicidal activities of human macrophages against Toxoplasma gondii and Trypanosoma cruzi.

Authors:  D M Israelski; F G Araujo; J S Wachtel; L Heinrichs; J S Remington
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 2.  Carbohydrate immunity in American trypanosomiasis.

Authors:  L R Travassos; I C Almeida
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage.

Authors:  R A Salata; R D Pearson; J I Ravdin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

Authors:  S L Newman; L Gootee; C Bucher; W E Bullock
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

6.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.

Authors:  H W Murray; D M Cartelli
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.

Authors:  A Nakagawara; N M DeSantis; N Nogueira; C F Nathan
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.